Common treatments may not be as effective for women as they are for men, mouse model reveals In a nutshell Research reveals ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

FDA reviews TNX-102 SL for Fibromyalgia by August 2025, with no advisory required. See why we recommend a buy on TNXP stock.

Tonix Pharma (TNXP) has submitted an NDA for its candidate TNX-102 SL for fibromyalgia, with a PDUFA date set for August 15, 2025. See why I'm on the sidelines.

Some forms of exercise training and pharmacological-based interventions may improve fibromyalgia-related sleep disturbances, though evidence is limited.

The FDA previously granted Fast Track designation to TNX-102 SL for the management of fibromyalgia in 2024, a designation intended to expedite FDA review of important new drugs to treat serious ...

Tonix Pharmaceuticals shares are trading higher by 22.5% during Monday's session. The company announced that the FDA will not ...

August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new ...

The following is a summary of “Treatments for enhancing sleep quality in fibromyalgia: a systematic review and meta-analysis, ...

Various showbiz personalities expressed their support for former host-actress Kris Aquino who praised her youngest ...

The blues and the jitters are very common among people battling chronic pain, a new evidence review says.About 40% of ...

A new government-funded study published in Pharmacology Reports has found that certain terpenes found in cannabis may provide effective relief for fibromyalgia and post-surgical pain. The research, ...